GW&K Investment Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
GW&K Investment Management's HALO Position: Q2 2026 in Review
GW&K Investment Management reduced its Halozyme (HALO) stake by 2.9% in Q2 2026, selling an estimated $2.73M and leaving 1,353,883 shares worth $106M. The position accounts for 0.83% of the portfolio, ranked #18.
GW&K Investment Management first reported a position in HALO in Q4 2020 and has held it in 23 quarters since. The position peaked at $119M in Q4 2022. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- GW&K Investment Management held 1,353,883 shares of Halozyme worth $106M as of Q2 2026.
- GW&K Investment Management sold 39,992 Halozyme shares in Q2 2026, an estimated $2.73M.
- Halozyme made up 0.83% of GW&K Investment Management's portfolio in Q2 2026, its #18 holding.
- GW&K Investment Management first reported a position in Halozyme in Q4 2020 and has held it in 23 quarters since.
- GW&K Investment Management's Halozyme position peaked at $119M in Q4 2022.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.